Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Personalized mRNA vaccine preps the body to battle deadly cancer
A new pancreatic cancer vaccine based on mRNA tech was shown to be safe and capable of triggering an immune response in a small trial.
Amish gene study finds clues to mood disorders like depression and bipolar disorder
Researchers have turned to this unique genetic population to find insights into how our genes play a role in mental health.
CRISPR sausage gets FDA green light for consumption
The FDA has given Washington State University researchers the green light to feed five gene-edited pigs to people.
Potential way to treat anorexia found in microbiome
New research links the gut microbiome, an ecosystem of viruses, bacteria, and fungi, to the development of anorexia nervosa.
New gene therapy could reverse a common cause of blindness
A new study suggests we may be able to convert dormant eye cells into photoreceptors to reverse retinal degeneration.
Rapamycin: The unlucky history of the most powerful anti-aging drug
When rapamycin research was revived, it was found to have both anti-cancer and anti-aging properties. Here’s what researchers say today.
Ultrasound could help us fight the deadliest cancer
In a small study, Northwestern researchers were able to get chemo drugs into the brains of glioblastoma patients with implanted ultrasound devices.
LSD flashbacks and a psychedelic disorder that can last forever
LSD flashbacks have been studied for decades, though scientists still aren’t quite sure why some people experience them.
AI helps terminal cancer patients make the most of their final days
An AI that encourages doctors to talk to cancer patients about their end-of-life care impacts how they choose to live out their final days.
AI dramatically improved mRNA vaccines in just 11 minutes
A new AI tool can find the most stable mRNA sequence for a vaccine, leading to more effective shots that are less prone to degradation.
New drug candidates found in an unlikely place
Costa Rica’s famed sloths harbor bacteria in their fur which can create antibiotic compounds — a potential source of future therapies.
Study: Parenthood seems to rewire gray matter
A study found that couples who co-parent together display similar brain activity, suggesting they become greatly attuned to each other.
World’s first vaccine for RSV approved in the US
The FDA has approved the world’s first vaccine for RSV, a potentially deadly viral infection that has long eluded vaccination.
The first fecal transplant pill is heading to pharmacies
The FDA approval of the first fecal transplant pill could kick off an era in which we target the gut microbiome to treat many other diseases.
More Americans than ever have no friends. Here are 5 steps to make more friends.
The last decade has seen a steep drop in adult friendships and a worrying increase in loneliness. Is this the cost of our modern life?
Ancient viruses in the human genome can help fight cancer
Armed with a DoD grant, researchers are harnessing the genetic code of ancient viral infections to fight prostate cancer.
Complex brain activity detected in dying patients
Researchers have measured gamma waves, a sign of brain activity, in patients who were dying.
New Alzheimer’s drug slows cognitive decline by 35%
Eli Lilly’s new Alzheimer’s drug, donanemab, slowed cognitive decline by 35% in a phase 3 trial, but two people died from side effects.
Networks of silver nanowires seem to learn and remember, much like our brains
Self-organising networks of tiny silver wires appear to learn and remember in much the same way as the thinking hardware in our heads.
Earbud-like tech will monitor sleep for signs of Parkinson’s
An EEG device that’s worn in the ear during sleep could help doctors diagnose Parkinson’s and Alzheimer’s long before symptoms appear.
Subscribe to the newsletter